Mechanisms of the Anti-Cancer and Anti-Inflammatory Actions of Vitamin D
Top Cited Papers
- 10 February 2011
- journal article
- review article
- Published by Annual Reviews in Annual Review of Pharmacology and Toxicology
- Vol. 51 (1), 311-336
- https://doi.org/10.1146/annurev-pharmtox-010510-100611
Abstract
Calcitriol, the hormonally active form of vitamin D, is being evaluated in clinical trials as an anti-cancer agent. Calcitriol exerts multiple anti-proliferative, pro-apoptotic, and pro-differentiating actions on various malignant cells and retards tumor growth in animal models of cancer. Calcitriol also exhibits several anti-inflammatory effects including suppression of prostaglandin (PG) action, inhibition of p38 stress kinase signaling, and the subsequent production of pro-inflammatory cytokines and inhibition of NF-κB signaling. Calcitriol also decreases the expression of aromatase, the enzyme that catalyzes estrogen synthesis in breast cancer, both by a direct transcriptional repression and indirectly by reducing PGs, which are major stimulators of aromatase transcription. Other important effects include the suppression of tumor angiogenesis, invasion, and metastasis. These calcitriol actions provide a basis for its potential use in cancer therapy and chemoprevention. We summarize the status of trials involving calcitriol and its analogs, used alone or in combination with known anti-cancer agents.Keywords
This publication has 98 references indexed in Scilit:
- Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancerTrends in Endocrinology & Metabolism, 2010
- Prostaglandins in bone: bad cop, good cop?Trends in Endocrinology & Metabolism, 2010
- Association of Nonsteroidal Anti-Inflammatory Drugs, Prostate Specific Antigen and Prostate VolumeJournal of Urology, 2009
- Cancer-related inflammationNature, 2008
- The role of hypoxia-inducible factors in tumorigenesisCell Death & Differentiation, 2008
- Pathways connecting inflammation and cancerCurrent Opinion in Genetics & Development, 2008
- 25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ cultureBreast Cancer Research and Treatment, 2008
- Targeting vasculature in urologic tumors: Mechanistic and therapeutic significanceJournal of Cellular Biochemistry, 2007
- The epidemiology of vitamin D and cancer incidence and mortality: A review (United States)Cancer Causes & Control, 2005
- NF-κB at the crossroads of life and deathNature Immunology, 2002